Running summarizing tools on a new article
Check the paper below, then start its synthesis.
Systematic Reclassification of Variants of Uncertain Significance in a Clinical Nephrogenomics Program: Insights from the RAPIDS Collaboration
Tung Lin Lee (SingHealth, Singapore General Hospital), 张耀春 (National University of Singapore, National University Health System), Tina Si Ting Lim (National University of Singapore, National University Health System), Chee Teck Koh (National University of Singapore, National University Health System), Kay Yuan Chong (Singapore General Hospital), Christina Titin (Singapore General Hospital), Hui Zhuan Tan (SingHealth, Singapore General Hospital), Irene Y. J. Mok (SingHealth, Singapore General Hospital), Jia Liang Kwek (SingHealth, Singapore General Hospital), Cynthia Ciwei Lim (SingHealth, Singapore General Hospital), Jason Chon Jun Choo (SingHealth, Singapore General Hospital), Jeannette Goh (National University of Singapore, SingHealth Duke-NUS Academic Medical Centre), Sylvia Kam (National University of Singapore, SingHealth Duke-NUS Academic Medical Centre), Breana Cham (National University of Singapore, SingHealth Duke-NUS Academic Medical Centre), Jiin Ying Lim (National University of Singapore, SingHealth Duke-NUS Academic Medical Centre), Ee Shien Tan (National University of Singapore, SingHealth Duke-NUS Academic Medical Centre), Esther Huimin Leow (KK Women's and Children's Hospital), Yong Hong Ng (KK Women's and Children's Hospital), Jia Ying Celeste Yap (KK Women's and Children's Hospital), Sing Ming Chao (KK Women's and Children's Hospital), Siew Le Chong (KK Women's and Children's Hospital), Ru Sin Lim (Tan Tock Seng Hospital), Su Mein Goh (Tan Tock Seng Hospital), Regina Shaoying Lim (Tan Tock Seng Hospital), See Cheng Yeo (Tan Tock Seng Hospital), Ziyin Wang (Tan Tock Seng Hospital), Chia Wei Lim (Tan Tock Seng Hospital), Dana Leng Hui Chan (Tan Tock Seng Hospital), David Lu (National University Health System), Sharon Teo (National University Health System), Perry Y W Lau (National University Health System), Mya Than (National University of Singapore, National University Health System), Jun Li Ng (National University of Singapore, National University Health System), Gek Cher Chan (National University of Singapore, National University Hospital), Yi Da (National University of Singapore, National University Hospital), Boon Wee Teo (National University of Singapore, National University Hospital), Hui‐Kim Yap (National University of Singapore, National University Health System), Hui-Lin L. Chin (National University of Singapore, National University Health System), Kar Hui Ng (National University of Singapore, National University Health System)
Abstract: Abstract Background A nationwide nephrologist-led genetic testing program for suspected monogenic glomerular disease and unexplained chronic kidney disease was implemented across four tertiary hospitals in Singapore. Initial testing yielded a genetic diagnosis in 11.5% probands, while 77 (18.4%) harboured variants of uncertain significance (VUS) that could explain their kidney disease (VUS-congruent). We evaluated a structured pipeline for reclassifying VUS-congruent to likely pathogenic or pathogenic (LP/P) to improve diagnostic yield and clinical utility. Methods Probands with VUS-congruent were reviewed at monthly multidisciplinary genomic board meetings. A stepwise framework incorporated genotype–phenotype correlations (Step 1), then re-appraisal of existing evidence (Step 2) through review of population databases, literature and in-silico prediction. For VUS with high suspicion of pathogenicity (VUS-High), resolution strategies were recommended (Step 3), including familial variant-specific testing, deeper phenotyping, and functional studies. Primary outcome was the proportion of VUS-congruent reclassified to LP/P; secondary outcomes were improvements in diagnostic yield and clinical utility. Results Among 418 probands tested over 28 months, 77 (18.4%) had VUS-congruent. Step 2 reclassified 26/77 VUS-congruent to LP/P, with another 22/77 VUS-congruent stratified as VUS-High. Among these 22 recommended for Step 3, completed strategies were functional studies (n=8), segregation analysis (n=1), deeper phenotyping (n=1), phase determination (n=1) and combination strategies (n=6). This enabled VUS-High reclassification to LP/P for 16 additional probands. Overall, 42/77 probands (54.5%) had VUS-congruent reclassified to LP/P, increasing diagnostic yield from 11.5% to 21.5%. Among these, 28 (66.7%) experienced clinically meaningful management changes. Conclusion A structured, multidisciplinary VUS resolution workflow enabled considerable VUS reclassification, nearly doubling the diagnostic yield.